Covered recipient · General Payments record
NICOLE ELIZABETH CAMPBELL
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2024
$608.96
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $608.96 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $291.62 | 20 |
| Janssen Biotech, Inc. | $83.46 | 4 |
| Acerta Pharma LLC | $71.86 | 4 |
| UCB, Inc. | $68.43 | 4 |
| PFIZER INC. | $55.92 | 3 |
| Aurinia Pharma U.S., Inc. | $23.85 | 1 |
| GlaxoSmithKline, LLC. | $13.82 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $608.96 | 37 |
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.87 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871521 | CMS |
| ABBVIE INC. | $5.59 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871523 | CMS |
| ABBVIE INC. | $20.23 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871525 | CMS |
| ABBVIE INC. | $13.88 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871527 | CMS |
| ABBVIE INC. | $19.27 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871529 | CMS |
| ABBVIE INC. | $15.69 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871531 | CMS |
| ABBVIE INC. | $6.96 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871533 | CMS |
| ABBVIE INC. | $22.50 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871535 | CMS |
| ABBVIE INC. | $20.96 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871537 | CMS |
| ABBVIE INC. | $7.85 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871539 | CMS |
| ABBVIE INC. | $16.29 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871541 | CMS |
| ABBVIE INC. | $8.06 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871543 | CMS |
| ABBVIE INC. | $12.33 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871545 | CMS |
| ABBVIE INC. | $9.34 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871547 | CMS |
| ABBVIE INC. | $20.14 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871549 | CMS |
| ABBVIE INC. | $19.30 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871551 | CMS |
| ABBVIE INC. | $10.04 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871553 | CMS |
| ABBVIE INC. | $18.51 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871555 | CMS |
| ABBVIE INC. | $22.28 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871557 | CMS |
| ABBVIE INC. | $13.53 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106871559 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.60 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105495585 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.30 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104515918 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.32 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104299696 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.64 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104557192 | CMS |
| Aurinia Pharma U.S., Inc. | $23.85 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150695880 | CMS |
| GlaxoSmithKline, LLC. | $13.82 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116115919 | CMS |
| Janssen Biotech, Inc. | $27.27 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078656295 | CMS |
| Janssen Biotech, Inc. | $24.75 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078656183 | CMS |
| Janssen Biotech, Inc. | $13.13 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078656126 | CMS |
| Janssen Biotech, Inc. | $18.31 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078656452 | CMS |
| PFIZER INC. | $26.62 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131997371 | CMS |
| PFIZER INC. | $15.19 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131072322 | CMS |
| PFIZER INC. | $14.11 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131413848 | CMS |
| UCB, Inc. | $16.47 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143077390 | CMS |
| UCB, Inc. | $18.54 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143073550 | CMS |
| UCB, Inc. | $17.48 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143073552 | CMS |
| UCB, Inc. | $15.94 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143073554 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.